New research reveals a potentially effective COVID-19 pill is in the works. Here’s what infectious disease experts want you ...
An experimental oral medication can dramatically lower the risk of getting COVID-19 after an exposure. The new pill, Ensitrelvir, is already approved for use in Japan. Infectious disease experts are ...
The drug showed promising results in an international study involving nearly 2,400 participants, and the U.S. Food and Drug ...
Ensitrelvir, an oral SARS-CoV-2 3C-like protease inhibitor, reduced symptomatic RT-PCR-confirmed COVID-19 among household ...
As per report, only one-third of countries meet WHO standards for high-quality mortality reporting. Around half of the data have low or very low-quality data, or no reliable mortality data systems in ...
I kept telling myself I was just being dramatic, but one blood test changed everything and may have saved my life.
Given that nearly everyone in the United States is believed to have had COVID, the 16 percent rate extrapolated to the ...
Engineers from the University of Houston, MIT and Harvard have developed a new mRNA-based strategy that dramatically amplifies the T-cell response to vaccines - an advance that could lead to far more ...
NexusHealth has an extensive ecosystem of experts – including innovation and commercialization leaders at McMaster – in all ...
Doctors across India are reporting a worrying rise in hip damage among younger adults after the COVID-19 pandemic. Experts say delayed diagnosis, sedentary lifestyles, and excessive steroid use during ...
Christine Taylor shared new details about her separation from Ben Stiller, revealing how years apart, therapy and an ...
"In 2020 — after three years of immunosuppression — when I learned of mRNA vaccine research for MS, I was relieved," writes Lindsay Karp. Then came the cuts to the federal government's budget for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results